FDA Clears Affymetrix Gene Expression Reagents for IVD Use

The use of the cleared reagents for clinical test development should lead to "more consistent results and lower commercialization costs for clinical providers and other Affymetrix customers."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.